UpdatesPress Release
Entero Healthcare acquired a 51.5% stake in Anand Chemiceutics, a diagnostic and MedTech solutions provider.
Entero Healthcare Solutions LimitedENTERO · Filed with the exchange
This expands Entero's presence in the high-growth MedTech market.
The MedTech segment is projected to contribute over INR 1,000 Cr in annualised revenue next financial year.
No comments yet. Be the first.